Richard Steinhart - May 14, 2022 Form 4 Insider Report for BioXcel Therapeutics, Inc. (BTAI)

Role
Senior VP and CFO
Signature
/s/ Richard I. Steinhart
Stock symbol
BTAI
Transactions as of
May 14, 2022
Transactions value $
$0
Form type
4
Date filed
5/17/2022, 03:40 PM
Previous filing
May 16, 2022
Next filing
Jul 1, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BTAI Restricted Stock Units Award $0 +5K $0.00 5K May 14, 2022 Common Stock 5K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs will vest and settle on May 14, 2023, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.